Kabuki syndrome (KS; OMIM 147920) is a mental retardation-malformation syndrome characterized by a peculiar face that is characterized by eversion of the lower lateral lids, arched eye brows with sparse or onethird dispersed lateral, depressed nasal tip and prominent ears; skeletal anomalies including brachydactyly and spinal deformity; dermatoglyphic abnormalities including: increased digital ulnar loop, presence of fingertip pads; mild to moderate mental retardation; and postnatal growth deficiency. This syndrome was first described in 1981 by Niikawa et al. 1 and Kuroki et al 2 . The prevalence of KS in the Japanese population has been estimated as 1/32.000 3 , and more than 400 cases have been described in the literature. Although it has been first described in the Japanese population, there have been numerous reports from other ethnic groups 4 , including patients of Turkish descent [5] [6] [7] [8] . It generally occurs because of a "de novo" mutation, involving either the myeloid/ lymphoid or mixed-lineage leukemia 2 (MLL2) gene 9 or less frequently the lysine (K)-specific demethylase 6A (KDM6A) gene 10, 11 . Here we report on a Turkish KS patient with epilepsy carrying a novel heterozygous mutation in the MLL2 gene.
Case Report
A male patient was referred to the pediatric neurology clinic because of a complex partial seizure characterized by unresponsiveness, at the age of 9. His past medical history included growth retardation, cryptorchidism, and hydronephrosis due to ureteropelvic stenosis. His parents were second-degree cousins; otherwise his family story was unremarkable. Physical examination revealed head circumference: 58 cm (+2SD), body height: 173 cm (25-50 th centile) and body weight: 99 kg (90-97 th centile). He had long palpebral fissures, bilateral ptosis, depressed nasal tip, prominent ears, high-arched palate, bilateral fetal finger pads and short fifth finger ( Fig. 1 ). Dysarthria and mild mental retardation (full-scale IQ score was 56) were noted in his neurological examination. His clinical findings led to the diagnosis of KS. Sequence analysis of MLL2 identified the heterozygous mutation c.12964C>T in exon 39. This mutation leads to a premature stop of MLL2 protein synthesis (p.Gln4322*). Both parents do not carry the mutation identified in their son.
The patient was put on carbamazepine, 600 mg/day and during the follow-up, he reported two similar seizures per year. His electroencephalogram (EEG) depicted paroxysmal sharp waves over the left parietooccipital region (Fig. 2) , however cranial magnetic resonance imaging (MRI) did not show any pathology. At the age of 18 years, he was admitted to the adult neurology department because of a secondary generalized tonic-clonic seizure despite treatment. Levetiracetam 2000 mg/day was added to his current medication and presently he is experiencing one complex partial seizure a year. 19 . Apart form these abnormalities, bilateral occipital polymicrogyria 18 , periventricular nodular heterotopia 6 , bilateral perisylvian polymicrogyria 20 , diffuse pachygyria 15 , and unilateral hippocampal atrophy 16 can undoubtedly be correlated with seizures. Like the majority of previous cases described in the literature, our patient also had a normal MRI, posteriorly located unilateral epileptiform discharges and very rare seizures with one or two anticonvulsant drugs. Although the mechanisms of seizures in KS are not clear, it has been hypothesized previously that both EEG abnormalities and seizures depend on diffuse brain hyperexcitability rather than abnormalities of cerebral structure 15 .
Discussion
Kabuki syndrome was a clinical diagnosis until 2010, when Ng and colleagues 21 identified MLL2 mutations for the first time, as the causative factor of the syndrome. Since then there have been several reports of patient series describing MLL2 mutations in 52-76% of the cases [9] [10] [11] [22] [23] [24] . MLL2 is a 36.3 kb gene located on chromosome 12q13.12 21 , and encodes a protein of 5537 amino acids which is located in a multiprotein complex. The synthesized protein is a histone H3 lysine 4 (H3K4)-specific methyltransferase that belongs to the SET1 family of human SET-domain protein methyltransferase superfamily 25 . H3K4 methylation is a transcriptional activation mechanism that regulates the transcription of a set of genes involved in embryogenesis and development 26 . The MLL2 gene is comprised of 54 exons and its mutations lead to loss of protein function and therefore repressed transcription of a variety of developmental genes, thus causing multiple organ involvement and characteristic phenotype of the syndrome. Mutations can be observed throughout the gene, however, a great majority of them are located in exons 39 and 48 9, 23 . Most mutations of the gene are nonsense, leading to formation of a truncated protein. Other mutations such as frameshift, missense and splice site, together with small duplications have also been described 22, 23 . Exon 39 contains several regions that encode long polyglutamine tracts suggesting the presence of a mutational hot spot, which could explain the high rate of mutations in this exon. About 300 mutations have been demonstrated in MLL2 gene so far 11 . The mutation identified in the present patient which leads to a truncated protein and thus most likely to haploinsufficiency of MLL2 has not yet been described in the literature. Therefore the present patient adds another novel mutation to the previous 45 mutations detected in exon 39 24 .
In conclusion, Kabuki syndrome is one of the most common causes of developmental delay, which is characterized by peculiar facial features, multiple organ involvement, mental retardation and seizures in some patients. It is not clear why cranial imaging findings can be so heterogeneous in KS. Further studies are needed to unravel the mechanisms of epileptogenesis, especially in patients with normal or nonspecific imaging results. As physicians' awareness of the syndrome increases, more patients are likely to be diagnosed.
